| Jeff Waugh, MD, PHD | |
|
2222 Medical District Dr, Dallas, TX 75235-8075 | |
| (214) 867-6900 | |
| Not Available |
| Full Name | Jeff Waugh |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology |
| Location | 2222 Medical District Dr, Dallas, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013138593 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0402X | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology | R5488 (Texas) | Primary |
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.
Patients living with heart failure receive palliative care significantly less often than patients with other illnesses, including cancer, despite evidence that such care improves symptom management and quality of life.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
The (Milwaukee) Business Journal explores the story of Serigraph, a West Bend, Wis., company which gave up on "fine-tuning" insurance coverage for workers and turned to concierge medicine instead. "Industry experts said the move is one that other employers likely will begin considering as they grapple with increasing health care costs."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeff Waugh, MD, PHD 1935 Medical District Dr, Dallas, TX 75235-7701 Ph: (214) 476-6628 | Jeff Waugh, MD, PHD 2222 Medical District Dr, Dallas, TX 75235-8075 Ph: (214) 867-6900 |
News Archive
A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.
Patients living with heart failure receive palliative care significantly less often than patients with other illnesses, including cancer, despite evidence that such care improves symptom management and quality of life.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
The (Milwaukee) Business Journal explores the story of Serigraph, a West Bend, Wis., company which gave up on "fine-tuning" insurance coverage for workers and turned to concierge medicine instead. "Industry experts said the move is one that other employers likely will begin considering as they grapple with increasing health care costs."
› Verified 8 days ago
Mr. Jonathan Devries, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-0580 | |
Abdullah Shoaib, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3916 Fax: 214-648-3916 | |
Michael R Rosenthal, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 8210 Walnut Hill Ln, #619, Dallas, TX 75231 Phone: 214-345-5630 Fax: 214-345-5632 | |
Steve A Roche, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 12850 Hillcrest Rd, Suite F-206, Dallas, TX 75230 Phone: 972-404-8253 Fax: 972-701-0874 | |
Catherine Karni, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-456-5900 | |
Dr. William Robert Olmsted, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8330 Meadow Rd, Ste 114, Dallas, TX 75231 Phone: 214-878-7442 Fax: 214-750-1971 | |
Dr. Inna Kogan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 13101 Preston Rd, Suite 504, Dallas, TX 75240 Phone: 469-791-9000 Fax: 469-791-9011 |